ライフサイエンスコーパス: postprocedure

1 portant clinical outcomes during the 30 days postprocedure.

2 TAVR did not improve their exercise capacity postprocedure.

3 14 U.S. sites and followed up for 12 months postprocedure.

4 target vessel revascularization) at 9 months postprocedure.

5 ng/mL increase in cTnT measured at 18-24 hrs postprocedure.

6 re in serum creatinine level within 96 hours postprocedure.

7 sive care unit stay (1 day), hospitalization postprocedure (4.5 days), and blood loss (1100 mL) all d

8 9+/-29.2% [P<0.0001]), but underestimated it postprocedure (6.9+/-11.3% versus 28.1+/-33.4% [P<0.0001

9 We investigated 3D intravascular ultrasound (postprocedure and 6 to 9 months) in 971 patients (267 wi

10 sound data >/=10 mm distal to the stent both postprocedure and at 9 months follow-up.

11 serial sera acquired over the first 10 days postprocedure and examined for correlation with achievem

12 Immediately postprocedure and then 1 mo later, patients rated their

13 ant changes in testosterone preprocedure and postprocedure, and all demonstrated significant increase

14 rd to percent obliteration of an aneurysm on postprocedure angiogram, the duration and intensity of a

15 toring, (d) intraprocedural control, and (e) postprocedure assessment.

16 on of patients with Troponin T levels >3xULN postprocedure (at 6 or 18-24 hours), where ULN stands fo

17 Postprocedure bleeding occurred in only 1 patient (SOC g

18 in would be associated with less in-hospital postprocedure bleeding than UFH but similar rates of in-

19 n in patients with significant coagulopathy, postprocedure bleeding was rare, indicating that TEG thr

20 compression), strong tumor blush, and major postprocedure blush reduction are predictors of clinical

21 The occurrence of postprocedure bursitis was recorded.

22 Efficacy end points and postprocedure cardiac enzyme were similar, but there was

23 imalist periprocedure approach, standardized postprocedure care with early mobilization and reconditi

24 ration, sedation, hemostatic techniques, and postprocedure care.

25 s to analyze the incidence and predictors of postprocedure chest pain (PPCP) after percutaneous coron

26 ocker therapy had lower persistent/recurrent postprocedure chest pain and lower preprocedure and post

27 Postprocedure chest pain is associated with similar shor

28 osition in the ipsilateral IJ as detected by postprocedure chest radiograph.

29 Routine postprocedure chest radiographs are considered standard

30 Data from standardized procedure notes and postprocedure chest radiographs were extracted and indiv

31 undergo diagnostic thoracentesis do not need postprocedure chest radiography.

32 s at 30 days and 6 months were stratified by postprocedure CK and CK-MB (multiple of the site's upper

33 The strongest correlate of postprocedure CK-MB elevation was the performance of dir

34 edure, early (24 hours), and late (9 months) postprocedure CMR imaging.

35 .18% [95% CI, 0.15%-0.20%]; P <.001) and any postprocedure complication (3.23% [95% CI, 3.01%-3.45%]

36 VE and hepatic resection was determined with postprocedure complication rate and median hospital stay

37 achieved in all procedures without intra- or postprocedure complications because there was high vascu

38 Postprocedure complications were less frequent with BVR

39 In the Medicare subset analyzed for postprocedure complications, there was no difference wit

40 There were no postprocedure complications.

41 Immediate postprocedure computed tomography (CT) of the abdomen he

42 utting the ablation zone was identified with postprocedure contrast material-enhanced computed tomogr

43 t in less myocardial necrosis as assessed by postprocedure creatine kinase (CK) levels.

44 ry intervention, we studied the incidence of postprocedure creatine kinase (CK)-MB elevation in patie

45 Compared with postprocedure day 1, every 90 days there is a decrease o

46 All patients reported relief of symptoms on postprocedure day 1.

47 anced multiphase MR imaging was performed on postprocedure days 1 and 30 and every 90 days thereafter

48 A postprocedure decrease in the hematocrit level of more t

49 bination of different stents (p = 0.013) and postprocedure dissections (p = 0.014) and slow flow (p =

50 was the numerical difference in new positive postprocedure DWMRI brain lesions at 2 days after TAVI i

51 , as well as a potentially decreased risk of postprocedure ectasia.

52 es, OCT-guided PCI is associated with higher postprocedure fractional flow reserve than PCI guided by

53 n a transaortic constriction model [at 10 wk postprocedure, fractional shortening was 0.31 +/- 0.02 i

54 Postprocedure gadolinium-enhanced MR imaging and clinica

55 Average postprocedure ghrelin values increased by 328.9 pg/dL +/

56 A successful result, defined as a postprocedure gradient of < or =20 mm Hg, was achieved i

57 cedure chest pain and lower preprocedure and postprocedure heart rates and mean blood pressures compa

58 Routine postprocedure heparin is not recommended, even in patien

59 ement, there has been a temporal decrease in postprocedure hospital admission.

60 Mean postprocedure hospital stay varied from 8 days to 51 day

61 Preliminary and postprocedure imaging is usually limited to CT for anato

62 e intention-to-treat population, at 3 months postprocedure, improvement in FEV1 from baseline was 13.

63 Thirteen patients developed postprocedure infection (1.5%), 9 (2.0%) in the white pe

64 However, DSAEK may also be associated with postprocedure intraocular pressure elevation and seconda

65 Postprocedure length of stay, days (1.4+/-0.2 radial vs.

66 Postprocedure lumen and vessel were not significantly di

67 ajor predictor of restenosis being a smaller postprocedure lumen diameter.

68 Inadequate postprocedure lumen dimensions, alone or in combination

69 er PCI, principally by resulting in a larger postprocedure lumen than with angiographic guidance.

70 At postprocedure, lumen VI at the stented segment was signi

71 han 1.0 cm (range, 1.1-2.6 cm) compared with postprocedure mammogram the day of placement, three of f

72 Postprocedure mammograms demonstrated accurate placement

73 ticoagulant treatment, nor did the immediate postprocedure mean intraocular pressure (P = .13).

74 , adjusting for baseline characteristics and postprocedure medications.

75 e vessel diameter, the PPCP group had larger postprocedure minimum lumen diameter, higher stent-to-ve

76 tly this involves no explicit comparisons of postprocedure mortality across hospitals.

77 o identify hospitals with statistically high postprocedure mortality rates.

78 n a large region of enhancement on immediate postprocedure MR images that, over time, involutes and i

79 Postprocedure MSA and follow-up minimum lumen area (MLA)

80 edictability of long-term stent patency with postprocedure MSA.

81 scularization was determined by the residual postprocedure myocardial jeopardy index (RMJI).

82 At 7 days postprocedure, no child had persistent behavioral abnorm

83 Postprocedure OCT was performed in all patients.

84 (0.3 mg/kg or 1 mg/kg) was i.v. administered postprocedure on days 0 and 5.

85 aditionally focused on processes of care and postprocedure outcomes.

86 PVL improved postprocedure (P<0.001) and was none (33.3%), mild (41.4

87 TSMB improved surgeon postprocedure pain scores in the neck, lower back, shoul

88 TSMB improved surgeon postprocedure pain scores in the neck, lower back, shoul

89 rine flow rates greater than 150 ml/h in the postprocedure period were significantly lower, 8/37 (21.

90 Postprocedure platelet counts increased only slightly (m

91 ion, ventilator-associated pneumonia/events, postprocedure pneumonia, methicillin-resistant Staphyloc

92 Comparative measurements from the postprocedure radiograph were made in 20 of these cases.

93 Sixteen patients had postprocedure radiographs performed.

94 ndred central venous catheter exchanges with postprocedure radiographs were evaluated in phase I.

95 determined primarily by the smaller lumen at postprocedure rather than exaggerated neointima within t

96 own a graded relationship with the degree of postprocedure renal failure and the probability of in-ho

97 with atherectomy plus PTCA resulted in lower postprocedure residual stenoses than PTCA alone (16+/-15

98 mediate renal denervation (n=47) and 6-month postprocedure results for crossover patients are present

99 Pre- and postprocedure SCr levels were assessed.

100 Postprocedure secondary patency with multiple PFSS proce

101 stents had significantly higher incidence of postprocedure strictures (P = 0.006).

102 Among patients in ARISTOTLE, the 30-day postprocedure stroke, death, and major bleeding rates we

103 During the 30 days postprocedure, stroke or systemic embolism occurred afte

104 nts at risk of significant cognitive decline postprocedures that benefit from targeted cognitive trai

105 there was a significant plaque increase from postprocedure to 9-month follow-up for PES (P=0.0008) bu

106 moral PCI 96.6%; P=0.182), or in the risk of postprocedure transfusion or mortality.

107 0.78 [95% CI, 0.67 to 0.90]; P = 0.001) and postprocedure transfusions (OR, 0.85 [CI, 0.74 to 0.96];

108 imes (at 1, 4, 24 hours and at 7 and 14 days postprocedure) until no longer detectable.

109 tion of the index limb at 30 days (+ 7 days) postprocedure was achieved in 99.2% (258/260) of patient

110 Average length of stay postprocedure was decreased significantly for both the M

111 eference segments, residual plaque burden at postprocedure was significantly greater in DM than in no

112 Freedom from atrial arrhythmias at 12 months postprocedure was similar compared with the primary stud

113 or behavioral abnormalities within 24 hours postprocedure was similar in both treatment groups.

114 The average postprocedure weight gain in experimental animals was si

115 phy/magnetic resonance imaging (also 6-month postprocedure) were performed.

116 hese remain well, off ERT (5, 4, and 3 years postprocedure), with gene marking in PBMC of 1%-10%, and

117 t of performing a brief but thorough routine postprocedure wound/body cavity exploration before wound

118 During the first postprocedure year, patients' angina burden and physical